Key2Brain is a biotech company committed to developing a novel brain targeting platform technology. With a library of unique lead molecules and preclinical expertise, Key2Brain provides solutions for enhanced brain uptake of biologics, with the goal to improve treatment options for diseases of the central nervous system.


Visit site